Skip to main content
Clinical Trials/TCTR20230929004
TCTR20230929004
Not yet recruiting
Phase 1

Oral supplementation of two different doses of vitamin D2 (Ergocalciferol) in stable preterm infants below 34 weeks gestational age in Queen Sirikit National Institute of Child Health

Children hospital foundation0 sites98 target enrollmentSeptember 29, 2023

Overview

Phase
Phase 1
Intervention
Not specified
Conditions
Vitamin D insufficiency or deficiency
Sponsor
Children hospital foundation
Enrollment
98
Status
Not yet recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
September 29, 2023
End Date
April 30, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Children hospital foundation

Eligibility Criteria

Inclusion Criteria

  • 1\.preterm infant below 34 weeks of gestational age and birthweight below 1800 grams
  • 2\.recieved full fortified human milk (150 ml/kg/day or more and 24kcal/oz)

Exclusion Criteria

  • exclude sample who has
  • 1\.major congenital anomaly
  • 2\.chromosomal abnormality
  • 3\.gastrointestinal abnormalities (obstruction or malabsorption)
  • 4\.major surgery
  • 5\. bone fracture
  • 6\.premature formular usued

Outcomes

Primary Outcomes

Not specified

Similar Trials